Eli Lilly's blockbuster weight-loss drug no longer in shortage in US: USFDA 0 03.10.2024 05:58 Business Standard The shortage of all doses of the drug, tirzepatide, sold as Mounjaro for diabetes and Zepbound for weight management has been resolved Moscow.media Частные объявления сегодня Rss.plus Все новости за 24 часа
